Clinical Trials Logo

Muscle Cramps clinical trials

View clinical trials related to Muscle Cramps.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02423395 Recruiting - Liver Cirrhosis Clinical Trials

Study of Orphenadrine` in the Treatment of Muscle Cramps in Patients With Cirrhosis

Start date: January 2015
Phase: Phase 3
Study type: Interventional

Muscle cramps are common in patients with liver disease and associated with significantly diminished quality of life. Patients with cirrhosis often experience muscle cramps with varied frequency and severity. The exact mechanisms by which they occur remain unclear, although a number of pathophysiological events unique to liver disease may contribute. Clinical studies have identified alterations in 3 areas: nerve function, energy metabolism, and plasma volume/electrolytes (1) Orphenadrine is an anticholinergic drug with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions. The combination of anticholinergic effects and CNS penetration make orphenadrine useful for pain of all etiologies, including from: radiculopathy, muscles, and headaches. [3,4]

NCT ID: NCT02221570 Recruiting - Liver Cirrhosis Clinical Trials

Baclofen in the Treatment of Muscle Cramps in Patients With Cirrhosis

Start date: June 2014
Phase: N/A
Study type: Interventional

Patients with cirrhosis often experience muscle cramps with varying severity. The mechanism of their occurrence is not yet understood. Muscle cramps in patients with cirrhosis are associated with significantly diminished quality of life. The aim of the study is to assess the efficacy of baclofen in the treatment of muscle cramps in patients with liver cirrhosis.